These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


338 related items for PubMed ID: 1370541

  • 1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
    Raiteri M, Garrone B, Pittaluga A.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):238-42. PubMed ID: 1370541
    [Abstract] [Full Text] [Related]

  • 2. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
    Pittaluga A, Raiteri M.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
    [Abstract] [Full Text] [Related]

  • 3. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC, Guet T, Bobichon C, Moreau C, Curutchet P, Lambolez B, de Carvalho LP, Cordi A, Lepagnol JM.
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [Abstract] [Full Text] [Related]

  • 4. A comparison of N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices.
    Hoehn K, Craig CG, White TD.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):174-81. PubMed ID: 2145421
    [Abstract] [Full Text] [Related]

  • 5. Ethanol inhibits N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat cortical slices.
    Gonzales RA, Woodward JJ.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1138-44. PubMed ID: 2162947
    [Abstract] [Full Text] [Related]

  • 6. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
    Verdoorn TA, Dingledine R.
    Mol Pharmacol; 1988 Sep; 34(3):298-307. PubMed ID: 2901662
    [Abstract] [Full Text] [Related]

  • 7. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
    Gonzales RA, Roper LC, Westbrook SL.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
    [Abstract] [Full Text] [Related]

  • 8. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
    Pittaluga A, Raiteri M.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):327-33. PubMed ID: 1357159
    [Abstract] [Full Text] [Related]

  • 9. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW.
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ethanol sensitivity of rat brain kainate, DL-alpha-amino-3-hydroxy-5-methyl-4-isoxalone proprionic acid and N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Dildy-Mayfield JE, Harris RA.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):487-94. PubMed ID: 1380078
    [Abstract] [Full Text] [Related]

  • 11. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E, Musante V, Neri E, Raiteri M, Pittaluga A.
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
    Fink K, Schultheiss R, Göthert M.
    Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.
    Curras MC, Dingledine R.
    Mol Pharmacol; 1992 Mar; 41(3):520-6. PubMed ID: 1372086
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
    Jones SM, Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD, Johnson KM.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [Abstract] [Full Text] [Related]

  • 18. Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. I. The role of glutamate.
    Lonart G, Johnson KM.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):7-13. PubMed ID: 7562597
    [Abstract] [Full Text] [Related]

  • 19. Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals.
    Risso F, Grilli M, Parodi M, Bado M, Raiteri M, Marchi M.
    Neuropharmacology; 2004 Jul; 47(1):65-71. PubMed ID: 15165834
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.
    Pittaluga A, Feligioni M, Longordo F, Arvigo M, Raiteri M.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):242-9. PubMed ID: 15608072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.